Literature DB >> 20626577

Investigation of suspected Guillain-Barre syndrome in childhood: what is the role for gadolinium enhanced magnetic resonance imaging of the spine?

Nicholas Smith1, John Pereira, Padraic Grattan-Smith.   

Abstract

AIM: To review the role of gadolinium-enhanced magnetic resonance imaging of the spine in the diagnosis of paediatric Guillain-Barre syndrome and compare it with nerve conduction studies and cerebrospinal fluid analysis.
METHODS: A retrospective review of investigations undertaken in children admitted to our institution with acute Guillain-Barre syndrome over a 10-year period was performed.
RESULTS: Seven of eight children (88%) displayed post-gadolinium nerve root enhancement consistent with Guillain-Barre syndrome. This compared with supportive nerve conduction studies in 21/24 children (88%) and cerebrospinal fluid protein analysis consistent with the diagnosis in 16/20 children (80%).
CONCLUSION: Nerve conduction studies are the recognised 'gold standard' technique for confirming a clinical diagnosis of Guillain-Barre syndrome. In this study, a high positive rate was demonstrated. While more experience is necessary, this study and the literature support gadolinium enhanced magnetic resonance imaging of the spine as a valuable, although not necessarily superior, investigation in the diagnosis of Guillain-Barre syndrome. It may be of particular benefit when specialist neurophysiology expertise is unavailable.
© 2010 The Authors. Journal compilation © 2010 Paediatrics and Child Health Division (Royal Australasian College of Physicians).

Entities:  

Keywords:  Guillain-Barre syndrome; magnetic resonance imaging; neurophysiology; paediatric

Mesh:

Substances:

Year:  2010        PMID: 20626577     DOI: 10.1111/j.1440-1754.2010.01802.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  1 in total

1.  Diagnosis of Guillain-Barré syndrome in children and validation of the Brighton criteria.

Authors:  Joyce Roodbol; Marie-Claire Y de Wit; Bianca van den Berg; Vivienne Kahlmann; Judith Drenthen; Coriene E Catsman-Berrevoets; Bart C Jacobs
Journal:  J Neurol       Date:  2017-03-01       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.